Pulmonary Arterial Hypertension Perspective

 
 
  • Remote Monitoring Systems in Heart Failure The latest implantable devices may help in preventing rehospitalization in patients with heart failure.
  • HFpEF Management: 5 Things to Know Although proven medical therapies for HFpEF are few, a stepwise set of management practices can help optimize care for patients with this condition.
  • Drug Treatment for COVID-19: A Quick Summary for PCPs Worldwide, scientists have launched over 1000 clinical trials of drugs for the treatment and prevention of SARS-CoV-2 since the start of January. Here's our very quick summary.
  • Let's Not Move at a Rapid Clip to Repair the Forgotten Valve Before we expand percutaneous repair of the forgotten valve with the CE-marked TriClip or off-label use of MitraClip, don't forget about the randomized trial, cautions John Mandrola, MD.
  • BSH 2020 Read clinically focused news coverage of key developments from British Society for Haematology (BSH) 2020 Annual Scientific Meeting
  • ACC 2020 Read clinically focused news coverage of key developments from ACC 2020
  • Do More HF Drugs Make It the Best or the Worst of Times?   New HF treatment regimens keep piling new drugs onto the old ones, making it less likely that patients will be able to adhere to the regimen, says Dr Ileana Piña.
  • In COPD, Carbon Dioxide Is Often Overlooked Dr Holley explains why more attention needs to be paid to carbon dioxide levels in patients with COPD and hypoxia.
  • Systemic Sclerosis Highlights From 2019 ACR Annual Meeting   Dr Robert Spiera of the Hospital for Special Surgery in New York City reviews key studies related to systemic sclerosis, presented at the 2019 American College of Rheumatology annual meeting.
  • Analyze This Image: All You Need Is an M-mode and a Doppler On the basis of the imaging studies, can you rule out the condition that is not consistent with the diagnosis?
  • Out With the Old, in With the New: The Role of Novelty Bias Are we overenamored of new drugs and treatments at the expense of older, proven therapies? The recent hoopla over CREDENCE and SONAR set Tejas Desai, MD, to ponder novelty bias.
  • TTR vs AL Cardiac Amyloidosis: Don't Rely on Imaging Alone   Drs Acharya, Grogan and Abou-Ezzeddine from Mayo discuss amyloid and TTR cardiac amyloidosis, with particular focus on diagnostic challenges and use of the pyrophosphate (PYP) scan.
  • What Is Sports Cardiology? Sports cardiology is an advancing field that encompasses the care of athletes and active individuals with known or previously undiagnosed cardiovascular conditions.
  • Calling Time on the Failure in Heart Failure   Optimal medical therapy and recent advances show that heart failure is preventable and not obligatory, Clyde Yancy tells Bob Harrington.
  • ACC 2019 Read clinically focused news coverage of key developments from ACC 2019
  • Echo Case: Four of a Kind Dr Wharton demonstrates an interesting and unusual case of a young adult with dyspnea, highlighting the value of M-mode echocardiography.
  • A 52-Year-Old Man With Dyspnea: USMLE Question A 52-year-old man presents with progressive dyspnea and purulent sputum production. What's the most likely diagnosis?
  • Echo Case: Possibly an All-Time Record Case of…   One of the worst cases Dr Wharton has seen. Can you decipher from the M-modes alone as the echocardiographers of old had to?
  • A 32-Year-Old Woman With Fatigue and Shortness of Breath A 32-year-old woman presents with fatigue and shortness of breath. Can you identify the best estimate of the mean physiologic pressure in the affected portion of the cardiovascular system?
  • More Diagnostic Errors in Patients With Pulmonary Symptoms These cases illustrate common diagnostic errors in patients presenting with pulmonary disease.